TAK-881

Other

Phase 3Mechanism not established
Phase 3topline reported

Evidence outlook · registrational

Primary Immunodeficiency: topline reported 2026-05-04

No completed mid-stage readout is on record. The sponsor reported topline results on 2026-05-04 (Positive topline results from Phase 2/3 TAK-881-3001 trial in PID). The announcement is listed under Regulatory events.

Source for the program status

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 3 (2)
Primary Immunodeficiency
NCT06076642 · Takeda
2024-11-04 – 2028-05-16 · Primary Immunodeficiency Diseases (PID)
What this study did
Other / comorbidity
NCT06747351 · Takeda
2025-05-06 – 2028-06-25 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
What this study did
Phase 2/3 (1)
Primary Immunodeficiency
NCT05755035 · Takeda
2023-10-24 – 2026-01-20 · Primary Immunodeficiency Diseases (PID)
What this study did
Phase 1 (3)
Other / comorbidity
NCT06935266 · Takeda
2025-04-22 – 2025-09-27 · Healthy Volunteers
What this study did
NCT06895967 · Takeda
2025-03-24 – 2025-08-08 · Healthy Volunteers
What this study did
NCT05059977 · Takeda
2021-10-12 – 2022-04-12 · Healthy Volunteers
What this study did

Competitive landscape

No competitors sharing a mechanism or indication in the current universe.

Upcoming events

(2 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow TAK-881 to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2028 (2)
May 2028 (1)
Phase 3Primary ImmunodeficiencyActive not recruiting
Est. primary completion 2028-05-16 · NCT06076642 · CT.gov ↗
What to watch
June 2028 (1)
Phase 3Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Recruiting
Est. primary completion 2028-06-25 · NCT06747351 · CT.gov ↗
What to watch

See the full readout calendar ↗

Regulatory and conference events

(1)

Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.

Recent

4 May 2026Topline resultPositive topline results from Phase 2/3 TAK-881-3001 trial in PID